Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.
作者信息
Nazha A, Al-Issa K, Hamilton B K, Radivoyevitch T, Gerds A T, Mukherjee S, Adema V, Zarzour A, Abuhadra N, Patel B J, Hirsch C M, Advani A, Przychodzen B, Carraway H E, Maciejewski J P, Sekeres M A
机构信息
Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
Department of Translational Hematology and Oncology Research, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
出版信息
Leukemia. 2017 Dec;31(12):2848-2850. doi: 10.1038/leu.2017.266. Epub 2017 Aug 18.
PMID:28819282
Abstract
摘要
Zotero 插件